Research On The Influential Factors Of The Clinical Curative Effect Of Medicated Bath Therapy To Treat Children’s Exogenous Fever (Wind-cold Type)

Objective①To determine the three key influential factors of the clinical curativeeffect of medicated bath therapy to treat children’s exogenous fever (wind-cold type),the medicated bath moment, the frequency of medicated bath and the medicated bathparts.②To provide the supportive research data to formulate the technicalspecifications of the medicated bath therapy.Methods64patient children who met the diagnostic criteria of exogenous fever werecollected, and randomly divided into8groups,8cases in each group, according to thedifferences in the medicated bath moment (pyrogenic stage or defervescence period),the frequency of medicated bath (1time a day or2times a day) and the medicatedbath parts (the whole body or the both feet). Children in Each group needed to taketwo kinds of oral medications, Pediatric Chai Gui Antifebrile Particles andCompoundParacetamolandMethylephedrineOralSolution, for2days. On this basis,each group’s children added their corresponding medicated bath treatment. Thetemperature variations in48hours after their treatments were observed in order tocompare the antifebrile effect in each group. The concrete evaluation indexes includedthe antifebrile onset time, the antipyretic time, the highest temperature decline, thearea under the temperature curve, the antifebrile effective rate and the number ofcombined use of antipyretic.Results①There was no significant difference among the groups in the antifebrileonset time (P=0.752>0.05);②The antipyretic times of the third group(pyrogenicstage,2times a day, the whole body bath)and the eighth group(defervescence period,2times a day, the both feet bath)were obviously shorter than the other groups (P=0.002<0.05);③The highest temperature decline of the third group(pyrogenic stage,2times a day, the whole body bath) on the first day and the second day wassignificantly higher than the other groups (P1=0.032<0.05, P2=0.002<0.05);④The areas under the temperature curve of the third group(pyrogenic stage,2times a day,the whole body bath)and the eighth group(defervescence period,2times a day, theboth feet bath)were obvious smaller than the other groups (P=0.015<0.05);⑤Therewas no significant difference between the groups in the antifebrile effective rate (P=0.748>0.05);⑥The Numbers of Combined use of antipyretic of the third group(pyrogenic stage,2times a day, the whole body bath) and the eighth group(defervescence period,2times a day, the both feet bath) were significantly less thanthe other groups (P=0.003<0.05).Conclusion①The optimal portfolio of the medicated bath moment, the frequency ofmedicated bath and the medicated bath parts for Medicated bath therapy to treatchildren’s exogenous fever (wind-cold type) was pyrogenic stage,2times a day, thewhole body and defervescence period,2times a day, the both feet.②Appropriatelyuse the Medicated bath therapy to treat children’s exogenous fever (wind-cold type) onthe basis of conventional treatment can obviously shorten the antipyretic time, reducethe patient’s thermal spike, decrease the area under the temperature curve, reduce theuse of antipyretic. But it can’t shorten the antifebrile onset time or influence the finalantifebrile effective rate.